Investing in PSC Unlocks Tax Benefits

Investing in PSC Unlocks Tax Benefits

Personalized Stem Cell was founded in 2018 to advance human regenerative medicine by securing FDA approval for autologous stem cell therapies for serious diseases with limited treatment options. PSC is raising a Series B round of $10 M dollars from qualified...